Welcome back to Endpoints Weekly! We had a small team in Chicago last weekend at this year’s ASCO conference. You’ll find a recap of their coverage below, including more details ...
June 6, 2026 06:00 AM EDT
Weekly
Lawmakers propose China restrictions; #ASCO26 recap; and more
Nicole DeFeudis
Welcome back to Endpoints Weekly! We had a small team in Chicago last weekend at this year’s ASCO conference. You’ll find a recap of their …
Behind the headlines of ASCO 2026
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
A turning point for pancreatic cancer patients
As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
ASCO 2026: key readouts in lung cancer - Pharmaceutical Technology
Pharmalittle: We're reading about pancreatic and lung cancer drugs, China biotech growth, and more
Coffee, racetracks, beaches and more coffee—inside the ASCO 2026 exhibit floor
Weekly Rundown: Trump signs AI executive order; Health Catalyst to sell Vitalware for $147M
ASCO26: Blood cancer readouts take centre stage - Pharmaceutical Technology
Welcome back to another edition of Endpoints Weekly. My usual colleague Nicole DeFeudis is out this week, so I’ve assembled the…
Welcome back to Endpoints Weekly! We’ve got a team of reporters on the ground in Chicago this weekend for ASCO, including my…
Welcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan…
Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s ann | Each…
It’s no secret that Akeso’s presentation will be one of the most closely watched readouts from the American Society of Clinical…
Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill…
